(pressebox) (Wiesbaden, 18.07.2013) A new family of LED-curable needle-bonding adhesives from Dymax Corporation has been formulated to cure at speeds typically associated with today’s best automation equipment and line speeds. Typical cure time for the 1400 series is 2.5 seconds or less, allowing for increased production speed and throughput, lower processing costs, and increased quality control with the aid of our patented fluorescing technology. These products have been specially engineering to cure with either 385 or 405 nm wavelengths, allowing for greater design flexibility within the automation process.

1400 Series needle bonders are available in 15-liter pails to minimize equipment downtime and material changeovers. They’ve passed ISO 10993-5 Cytotoxicity testing and support short-term (<29 days) implantation or single-use disposable device applications. Dymax MD® Medical Device Adhesives contain no nonreactive solvents, and are compatible with gamma, EtO, and E-Beam sterilization.

Über DYMAX Europe GmbH: DYMAX is a leading global manufacturer of light-curing materials, dispensing and curing equipment. For over 30 years, the company develops innovative solutions for industrial applications in the fields of medical, electronics, automotive, aerospace, solar energy, telecommunications, home appliances and glass industries. The headquarter is located in Torrington, Connecticut, USA. Today, Dymax has 240 employees globally with additional facilities in Germany, China, Hong Kong, and Korea.